Laatzen, Germany

Angela Romanow

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medizinische Hochschule Hannover. Active years: 2019.


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angela Romanow: Innovator in Capsular Polysaccharide Production

Introduction

Angela Romanow is a notable inventor based in Laatzen, Germany. She has made significant contributions to the field of biotechnology, particularly in the production of capsular polysaccharides. Her innovative work has implications for pharmaceuticals, especially in vaccine development.

Latest Patents

Angela Romanow holds a patent titled "Means and methods for producing capsular polysaccharides of low dispersity." This invention relates to in vitro methods for producing capsular polysaccharides with a defined length. The patent also describes compositions that include at least one capsule polymerase, one donor carbohydrate, and one acceptor carbohydrate, with a specific ratio of donor to acceptor carbohydrates ranging from 10:1 to 400:1. Additionally, the invention provides truncated versions of capsule polymerases from serogroups A and X. The patent further outlines methods for producing vaccines that incorporate these synthetic capsular polysaccharides.

Career Highlights

Angela Romanow is affiliated with the Medizinische Hochschule Hannover, where she continues her research and development efforts. Her work has positioned her as a key figure in the advancement of biotechnological methods for vaccine production.

Collaborations

Angela has collaborated with notable colleagues, including Friedrich Freiberger and Andrea Bethe, to enhance her research initiatives and drive innovation in her field.

Conclusion

Angela Romanow's contributions to the production of capsular polysaccharides represent a significant advancement in biotechnology and vaccine development. Her innovative approaches and collaborative efforts continue to influence the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…